Piramal Pharma Solutions to provide Bolt Biotherapeutics with immune-stimulating antibody conjugates… EP News Bureau Jul 29, 2020 Bolt’s Boltbody Immune Stimulating Antibody Conjugate (ISAC), BDC-1001, is currently in a first-in-human Phase 1/2 clinical study…